Brief: Jenscare Scientific Posts H1 Net Loss Of RMB102.3 Mln
27/08/2024 23:06
Aug 28 (Reuters) - Jenscare Scientific H1 net income RMB -102.3 million. * H1 pretax profit RMB -105.8 million
Recent news on Jenscare Scientific Co
See all newsBrief: Jenscare Scientific Says Ken-Valve Transcatheter Aortic Valve Replacement System Receives HK Approval
Brief: Jenscare Scientific Posts FY Revenue Of RMB90.6 Million
Brief: Jenscare Scientific Appoints Li Yuanyuan As CFO
Brief: Jenscare Scientific Receives NZ Approval For Ken-Valve And Lux-Valve Plus
Brief: Jenscare Scientific Says Lux-Valve Plus Receives FDA IDE Approval For Pivotal Trial